Strong Q1; full-year outlook maintained
12/05/22 -"Alcon has started 2022 on a good note, with continued strong growth momentum being witnessed across the segments. While spiralling inflation and FX headwinds, due to rising geopolitical crisis and ..."
Pages
50
Language
English
Published on
12/05/22
You may also be interested by these reports :
10/02/26
Philips’ Q4 results exceeded expectations, with comparable sales growth driven by strong performance in Personal Health and healthy contributions ...
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...
05/02/26
GN’s Q4 results fell short of market expectations. While Hearing experienced healthy growth, this was overshadowed by weaknesses in Gaming and ...